3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Neoplasms
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lung Neoplasms
1
Interventions
pembrolizumab
223
Cyclophosphamide
192
Radiotherapy
183
Nivolumab
181
Carboplatin
153
Cisplatin
114
Paclitaxel
112
Dexamethasone
110
Radiosurgery
103
Magnetic Resonance Spectroscopy
97
Surveys and Questionnaires
90
Ipilimumab
81
Doxorubicin
79
Lenalidomide
76
Rituximab
75
durvalumab
74
atezolizumab
72
Radiation
72
fludarabine
68
Standard of Care
68
Gemcitabine
68
venetoclax
67
Specimen Handling
65
Etoposide
64
Capecitabine
64
Bevacizumab
62
Oxaliplatin
59
Docetaxel
58
Biopsy
58
Radiotherapy, Intensity-Modulated
56
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
OTHER
×
UV1 vaccine
×
Clear all
NCT04300244
2024-02-29
NIPU
Oslo University Hospital
Phase 2
Active not recruiting
118 enrolled